Agency Information Collection Activities; Proposed Collection; Comment Request; Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002, 12366-12368 [2023-03991]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES
12366
Federal Register / Vol. 88, No. 38 / Monday, February 27, 2023 / Notices
scroll down to the appropriate advisory
committee meeting link, or call the
advisory committee information line to
learn about possible modifications
before the meeting.
SUPPLEMENTARY INFORMATION:
Agenda: The meeting presentations
will be heard, viewed, captioned, and
recorded through an online
teleconferencing platform. The
committee will discuss new drug
application (NDA) 217188, for
PAXLOVID (nirmatrelvir and ritonavir
co-packaged tablets) for oral use,
submitted by Pfizer, Inc. The proposed
indication is treatment of mild-tomoderate coronavirus disease (COVID–
19) in adults who are at high risk for
progression to severe COVID–19,
including hospitalization or death.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its website prior to the
meeting, the background material will
be made publicly available on FDA’s
website at the time of the advisory
committee meeting. Background
material and the link to the online
teleconference meeting room will be
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link. The meeting will include slide
presentations with audio components to
allow the presentation of materials in a
manner that most closely resembles an
in-person advisory committee meeting.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. All electronic and
written submissions to the Docket (see
ADDRESSES) on or before March 9, 2023,
will be provided to the committee. Oral
presentations from the public will be
scheduled between approximately 1:30
p.m. and 2:30 p.m. Eastern Time. Those
individuals interested in making formal
oral presentations should notify the
contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before March 2, 2023. Time allotted
for each presentation may be limited. If
the number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
VerDate Sep<11>2014
20:06 Feb 24, 2023
Jkt 259001
notify interested persons regarding their
request to speak by March 3, 2023.
For press inquiries, please contact the
Office of Media Affairs at fdaoma@
fda.hhs.gov or 301–796–4540.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact Joyce
Frimpong (see FOR FURTHER INFORMATION
CONTACT) at least 7 days in advance of
the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our website at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: February 22, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–03971 Filed 2–24–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2023–N–0465]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Prior Notice of
Imported Food Under the Public Health
Security and Bioterrorism
Preparedness and Response Act of
2002
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA, Agency, or we) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection provisions of our regulations
requiring that the Agency receive prior
SUMMARY:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
notice before food is imported or offered
for import into the United States.
DATES: Either electronic or written
comments on the collection of
information must be submitted by April
28, 2023.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. The https://
www.regulations.gov electronic filing
system will accept comments until
11:59 p.m. Eastern Time at the end of
April 28, 2023. Comments received by
mail/hand delivery/courier (for written/
paper submissions) will be considered
timely if they are received on or before
that date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
E:\FR\FM\27FEN1.SGM
27FEN1
ddrumheller on DSK120RN23PROD with NOTICES
Federal Register / Vol. 88, No. 38 / Monday, February 27, 2023 / Notices
2023–N–0465 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request; Prior
Notice of Imported Food Under the
Public Health Security and Bioterrorism
Preparedness and Response Act of
2002.’’ Received comments, those filed
in a timely manner (see ADDRESSES),
will be placed in the docket and, except
for those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Amber Sanford, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
VerDate Sep<11>2014
20:06 Feb 24, 2023
Jkt 259001
20852, 301–796–8867, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3521), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Prior Notice of Imported Food Under
the Public Health Security and
Bioterrorism Preparedness and
Response Act of 2002—21 CFR 1.278 to
1.285
OMB Control Number 0910–0520—
Extension
The Public Health Security and
Bioterrorism Preparedness and
Response Act of 2002 (Bioterrorism Act)
added section 801(m) of the Federal
Food, Drug, and Cosmetic Act (FD&C
Act) (21 U.S.C. 381(m)), which requires
that FDA receive prior notice for food,
including food for animals, that is
imported or offered for import into the
United States. Sections 1.278 to 1.282 of
FDA regulations (21 CFR 1.278 to 1.282)
set forth the requirements for submitting
prior notice; §§ 1.283(d) and 1.285(j) (21
CFR 1.283(d) and 1.285(j)) set forth the
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
12367
procedure for requesting Agency review
after FDA has refused admission of an
article of food under section 801(m)(1)
of the FD&C Act or placed an article of
food under hold under section 801(l) of
the FD&C Act; and § 1.285(i) sets forth
the procedure for post-hold
submissions.
Section 304 of the FDA Food Safety
Modernization Act (Pub. L. 111–353)
amended section 801(m) of the FD&C
Act to require a person submitting prior
notice of imported food, including food
for animals, to report, in addition to
other information already required,
‘‘any country to which the article has
been refused entry.’’ Advance notice of
imported food allows FDA, with the
support of the U.S. Customs and Border
Protection (CBP), to target import
inspections more effectively and help
protect the nation’s food supply against
terrorist acts and other public health
emergencies. By requiring that a prior
notice contain specific information that
indicates prior refusals by any country
and identifies the country or countries,
the Agency may better identify imported
food shipments that may pose safety
and security risks to U.S. consumers.
This information collection enables
FDA to make better informed decisions
in managing the potential risks of
imported food shipments into the
United States. Any person with
knowledge of the required information
may submit prior notice for an article of
food. Thus, the respondents to this
information collection may include
importers, owners, ultimate consignees,
shippers, and carriers.
FDA regulations require that prior
notice of imported food be submitted
electronically using CBP’s Automated
Broker Interface of the Automated
Commercial Environment (ABI/ACE)
(§ 1.280(a)(1)) or the FDA Prior Notice
System Interface (PNSI) (Form FDA
3540) (§ 1.280(a)(2)). PNSI is an
electronic submission system available
on the FDA Industry Systems page at
https://www.access.fda.gov/.
Information the Agency collects in the
prior notice submission includes: (1) the
submitter and transmitter (if different
from the submitter); (2) entry type and
CBP identifier; (3) the article of food,
including complete FDA product code;
(4) the manufacturer, for an article of
food no longer in its natural state; (5)
the grower, if known, for an article of
food that is in its natural state; (6) the
FDA Country of Production; (7) the
name of any country that has refused
entry of the article of food; (8) the
shipper, except for food imported by
international mail; (9) the country from
which the article of food is shipped or,
if the food is imported by international
E:\FR\FM\27FEN1.SGM
27FEN1
12368
Federal Register / Vol. 88, No. 38 / Monday, February 27, 2023 / Notices
mail, the anticipated date of mailing and
country from which the food is mailed;
(10) the anticipated arrival information
or, if the food is imported by
international mail, the U.S. recipient;
(11) the importer, owner, and ultimate
consignee, except for food imported by
international mail or transshipped
through the United States; (12) the
carrier and mode of transportation,
except for food imported by
international mail; and (13) planned
shipment information, except for food
imported by international mail (§ 1.281).
Much of the information collected for
prior notice is identical to the
information collected for FDA
importer’s entry notice, which has been
approved under OMB control number
0910–0046. The information in an
importer’s entry notice is collected
electronically via CBP’s ABI/ACE at the
same time the respondent files an entry
for import with CBP. To avoid doublecounting the burden hours already
counted in the importer’s entry notice
information collection, the burden hour
analysis in table 1 reflects FDA’s
estimate of the reduced burden for prior
notice submitted through ABI/ACE in
column 6 entitled ‘‘Average Burden per
Response.’’
In addition to submitting a prior
notice, a submitter should cancel a prior
notice and must resubmit the
information to FDA if information
changes after the Agency has confirmed
a prior notice submission for review
(e.g., if the identity of the manufacturer
changes) (§ 1.282). However, changes in
the estimated quantity, anticipated
arrival information, or planned
shipment information do not require
resubmission of prior notice after the
Agency has confirmed a prior notice
submission for review (§ 1.282(a)(1)(i) to
(iii)). In the event that FDA refuses
admission to an article of food under
section 801(m)(1) or the Agency places
it under hold under section 801(l) of the
FD&C Act, §§ 1.283(d) and 1.285(j) (21
CFR 1.283(d) and 1.285(j)) set forth the
procedure for requesting FDA’s review
and the information required in a
request for review. In the event that the
Agency places an article of food under
hold under § 801(l) of the FD&C Act,
§ 1.285(i) (21 CFR 1.285(i)) sets forth the
procedure for, and the information to be
included in, a post-hold submission.
We estimate the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
21 CFR section
FDA form No.
Prior Notice Submissions:
Through ABI/ACE
1.280 through 1.281 ..............................................
Through PNSI
1.280 through 1.281 ..............................................
Subtotal ..........................................................
Cancellations:
Through ABI/ACE
1.282 .....................................................................
Through PNSI
1.282 and 1.283(a)(5) ...........................................
Subtotal ..........................................................
Requests for Review and Post-hold Submissions:
1.283(d) and 1.285(j) ............................................
1.285(i) ..................................................................
Subtotal ..........................................................
Total ........................................................
Number of
respondents
Number of
responses per
respondent
Total annual
responses
Average burden per
response
Total hours
N/A
1,900
7,895
15,000,500
0.167 (10 minutes) .....
2 2,505,084
3 3540
........................
13,000
........................
231
........................
3,003,000
........................
0.384 (23 minutes) .....
.....................................
1,153,152
3,658,236
N/A
25,000
1
25,000
0.25 (15 minutes) .......
6,250
3540
........................
50,000
........................
1
........................
50,000
........................
0.25 (15 minutes) .......
.....................................
12,500
18,750
N/A
N/A
........................
1
500
........................
1
1
........................
1
500
........................
8 ..................................
1 ..................................
.....................................
8
500
508
........................
........................
........................
18,079,001
.....................................
3,677,494
1
ddrumheller on DSK120RN23PROD with NOTICES
There are no capital costs or operating and maintenance costs associated with this collection of information.
2 To avoid double counting, an estimated 396,416 burden hours already accounted for in the importer’s entry notice information collection approved under OMB
control number 0910–0046 are not included in the total.
3 The term ‘‘Form FDA 3540’’ refers to the electronic submission system known as PNSI, which is available at https://www.access.fda.gov/.
Table 1 reflects the annual estimated
reporting burden associated with the
information collection. During the next
3 years, we estimate each respondent
will need approximately 10 minutes per
submission for a total of 15,000,500
annual submissions and 2,505,083.5
rounded up to 2,505,084 annual hours
of burden. Similarly, we estimate 13,000
users submitting an average of 231
notices annually, requiring
approximately 23 minutes per
submission. Cumulatively, this totals
3,003,000 annual responses and
1,153,152 annual hours of burden.
Regarding cancellations of prior
notices, we estimate 25,000 respondents
averaging 1 cancellation annually and
requiring 15 minutes to do so.
Cumulatively this totals 25,000 annual
submissions and 6,250 annual hours of
burden. Similarly, we estimate 50,000
VerDate Sep<11>2014
20:06 Feb 24, 2023
Jkt 259001
registered users submitting an average of
1 cancellation annually and requiring 15
minutes to do so. Cumulatively this
totals 50,000 annual responses and
12,500 annual hours of burden.
We estimate that we will receive one
submission annually under § 1.283(d) or
§ 1.285(j) over the next 3 years. It takes
approximately 8 hours to prepare a
submission, which results in 8 hours of
burden.
Finally, for an average of 500 posthold submissions annually, we estimate
it will take respondents 1 hour to
prepare the written notification
described in § 1.285(i)(2)(i), for a total of
500 annual burden hours.
Based on our experience and the
average number of prior notice
submissions, cancellations, and requests
for review received in the past 3 years,
we are adjusting our burden estimate for
PO 00000
Frm 00062
Fmt 4703
Sfmt 9990
this information collection by increasing
the number of responses and total
burden. The number of responses has
increased by 3,146,589 responses (from
14,932,412 to 18,079,001). The total
burden has increased by 769,918 hours
(from 2,907,576 to 3,677,494). We
attribute the adjustment to an increase
in the number of responses.
Dated: February 22, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–03991 Filed 2–24–23; 8:45 am]
BILLING CODE 4164–01–P
E:\FR\FM\27FEN1.SGM
27FEN1
]]>Agencies
[Federal Register Volume 88, Number 38 (Monday, February 27, 2023)]
[Notices]
[Pages 12366-12368]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03991]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2023-N-0465]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Prior Notice of Imported Food Under the Public Health
Security and Bioterrorism Preparedness and Response Act of 2002
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA, Agency, or we) is
announcing an opportunity for public comment on the proposed collection
of certain information by the Agency. Under the Paperwork Reduction Act
of 1995 (PRA), Federal Agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on the information collection
provisions of our regulations requiring that the Agency receive prior
notice before food is imported or offered for import into the United
States.
DATES: Either electronic or written comments on the collection of
information must be submitted by April 28, 2023.
ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of April 28, 2023. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are received on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-
[[Page 12367]]
2023-N-0465 for ``Agency Information Collection Activities; Proposed
Collection; Comment Request; Prior Notice of Imported Food Under the
Public Health Security and Bioterrorism Preparedness and Response Act
of 2002.'' Received comments, those filed in a timely manner (see
ADDRESSES), will be placed in the docket and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday, 240-402-7500.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-8867,
[email protected].
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
Prior Notice of Imported Food Under the Public Health Security and
Bioterrorism Preparedness and Response Act of 2002--21 CFR 1.278 to
1.285
OMB Control Number 0910-0520--Extension
The Public Health Security and Bioterrorism Preparedness and
Response Act of 2002 (Bioterrorism Act) added section 801(m) of the
Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 381(m)),
which requires that FDA receive prior notice for food, including food
for animals, that is imported or offered for import into the United
States. Sections 1.278 to 1.282 of FDA regulations (21 CFR 1.278 to
1.282) set forth the requirements for submitting prior notice;
Sec. Sec. 1.283(d) and 1.285(j) (21 CFR 1.283(d) and 1.285(j)) set
forth the procedure for requesting Agency review after FDA has refused
admission of an article of food under section 801(m)(1) of the FD&C Act
or placed an article of food under hold under section 801(l) of the
FD&C Act; and Sec. 1.285(i) sets forth the procedure for post-hold
submissions.
Section 304 of the FDA Food Safety Modernization Act (Pub. L. 111-
353) amended section 801(m) of the FD&C Act to require a person
submitting prior notice of imported food, including food for animals,
to report, in addition to other information already required, ``any
country to which the article has been refused entry.'' Advance notice
of imported food allows FDA, with the support of the U.S. Customs and
Border Protection (CBP), to target import inspections more effectively
and help protect the nation's food supply against terrorist acts and
other public health emergencies. By requiring that a prior notice
contain specific information that indicates prior refusals by any
country and identifies the country or countries, the Agency may better
identify imported food shipments that may pose safety and security
risks to U.S. consumers.
This information collection enables FDA to make better informed
decisions in managing the potential risks of imported food shipments
into the United States. Any person with knowledge of the required
information may submit prior notice for an article of food. Thus, the
respondents to this information collection may include importers,
owners, ultimate consignees, shippers, and carriers.
FDA regulations require that prior notice of imported food be
submitted electronically using CBP's Automated Broker Interface of the
Automated Commercial Environment (ABI/ACE) (Sec. 1.280(a)(1)) or the
FDA Prior Notice System Interface (PNSI) (Form FDA 3540) (Sec.
1.280(a)(2)). PNSI is an electronic submission system available on the
FDA Industry Systems page at https://www.access.fda.gov/. Information
the Agency collects in the prior notice submission includes: (1) the
submitter and transmitter (if different from the submitter); (2) entry
type and CBP identifier; (3) the article of food, including complete
FDA product code; (4) the manufacturer, for an article of food no
longer in its natural state; (5) the grower, if known, for an article
of food that is in its natural state; (6) the FDA Country of
Production; (7) the name of any country that has refused entry of the
article of food; (8) the shipper, except for food imported by
international mail; (9) the country from which the article of food is
shipped or, if the food is imported by international
[[Page 12368]]
mail, the anticipated date of mailing and country from which the food
is mailed; (10) the anticipated arrival information or, if the food is
imported by international mail, the U.S. recipient; (11) the importer,
owner, and ultimate consignee, except for food imported by
international mail or transshipped through the United States; (12) the
carrier and mode of transportation, except for food imported by
international mail; and (13) planned shipment information, except for
food imported by international mail (Sec. 1.281).
Much of the information collected for prior notice is identical to
the information collected for FDA importer's entry notice, which has
been approved under OMB control number 0910-0046. The information in an
importer's entry notice is collected electronically via CBP's ABI/ACE
at the same time the respondent files an entry for import with CBP. To
avoid double-counting the burden hours already counted in the
importer's entry notice information collection, the burden hour
analysis in table 1 reflects FDA's estimate of the reduced burden for
prior notice submitted through ABI/ACE in column 6 entitled ``Average
Burden per Response.''
In addition to submitting a prior notice, a submitter should cancel
a prior notice and must resubmit the information to FDA if information
changes after the Agency has confirmed a prior notice submission for
review (e.g., if the identity of the manufacturer changes) (Sec.
1.282). However, changes in the estimated quantity, anticipated arrival
information, or planned shipment information do not require
resubmission of prior notice after the Agency has confirmed a prior
notice submission for review (Sec. 1.282(a)(1)(i) to (iii)). In the
event that FDA refuses admission to an article of food under section
801(m)(1) or the Agency places it under hold under section 801(l) of
the FD&C Act, Sec. Sec. 1.283(d) and 1.285(j) (21 CFR 1.283(d) and
1.285(j)) set forth the procedure for requesting FDA's review and the
information required in a request for review. In the event that the
Agency places an article of food under hold under Sec. 801(l) of the
FD&C Act, Sec. 1.285(i) (21 CFR 1.285(i)) sets forth the procedure
for, and the information to be included in, a post-hold submission.
We estimate the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
21 CFR section FDA form No. Number of responses per Total annual Average burden per response Total hours
respondents respondent responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Prior Notice Submissions:
Through ABI/ACE
1.280 through 1.281.............. N/A 1,900 7,895 15,000,500 0.167 (10 minutes)............... \2\ 2,505,084
Through PNSI
1.280 through 1.281.............. \3\ 3540 13,000 231 3,003,000 0.384 (23 minutes)............... 1,153,152
Subtotal..................... .............. .............. .............. .............. ................................. 3,658,236
Cancellations:
Through ABI/ACE
1.282............................ N/A 25,000 1 25,000 0.25 (15 minutes)................ 6,250
Through PNSI
1.282 and 1.283(a)(5)............ 3540 50,000 1 50,000 0.25 (15 minutes)................ 12,500
Subtotal..................... .............. .............. .............. .............. ................................. 18,750
Requests for Review and Post-hold
Submissions:
1.283(d) and 1.285(j)............ N/A 1 1 1 8................................ 8
1.285(i)......................... N/A 500 1 500 1................................ 500
Subtotal..................... .............. .............. .............. .............. ................................. 508
--------------------------------------------------------------------------------------------------
Total.................... .............. .............. .............. 18,079,001 ................................. 3,677,494
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
\2\ To avoid double counting, an estimated 396,416 burden hours already accounted for in the importer's entry notice information collection approved
under OMB control number 0910-0046 are not included in the total.
\3\ The term ``Form FDA 3540'' refers to the electronic submission system known as PNSI, which is available at https://www.access.fda.gov/.
Table 1 reflects the annual estimated reporting burden associated
with the information collection. During the next 3 years, we estimate
each respondent will need approximately 10 minutes per submission for a
total of 15,000,500 annual submissions and 2,505,083.5 rounded up to
2,505,084 annual hours of burden. Similarly, we estimate 13,000 users
submitting an average of 231 notices annually, requiring approximately
23 minutes per submission. Cumulatively, this totals 3,003,000 annual
responses and 1,153,152 annual hours of burden.
Regarding cancellations of prior notices, we estimate 25,000
respondents averaging 1 cancellation annually and requiring 15 minutes
to do so. Cumulatively this totals 25,000 annual submissions and 6,250
annual hours of burden. Similarly, we estimate 50,000 registered users
submitting an average of 1 cancellation annually and requiring 15
minutes to do so. Cumulatively this totals 50,000 annual responses and
12,500 annual hours of burden.
We estimate that we will receive one submission annually under
Sec. 1.283(d) or Sec. 1.285(j) over the next 3 years. It takes
approximately 8 hours to prepare a submission, which results in 8 hours
of burden.
Finally, for an average of 500 post-hold submissions annually, we
estimate it will take respondents 1 hour to prepare the written
notification described in Sec. 1.285(i)(2)(i), for a total of 500
annual burden hours.
Based on our experience and the average number of prior notice
submissions, cancellations, and requests for review received in the
past 3 years, we are adjusting our burden estimate for this information
collection by increasing the number of responses and total burden. The
number of responses has increased by 3,146,589 responses (from
14,932,412 to 18,079,001). The total burden has increased by 769,918
hours (from 2,907,576 to 3,677,494). We attribute the adjustment to an
increase in the number of responses.
Dated: February 22, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-03991 Filed 2-24-23; 8:45 am]
BILLING CODE 4164-01-P
